Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Recruiting · NCT02781883 · Registry updated 2025-03-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-03-07 | NCT02781883 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bio-Path Holdings, Inc. | 4 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor Scott & White Research Institute | Temple | United States | 5 |
| Georgia Cancer Center at Augusta University | Augusta | United States | 23 |
| Laura & Isaac Pe lmutter Cancer Center at NYU Langone Health | New York | United States | 1 |
| New Jersey Hematology Oncology Associates | Brick | United States | 1 |
| UCLA Medical Center | Los Angeles | United States | 42 |
| University of Kansas Cancer Center | Fairway | United States | 8 |
| University of Texas M.D. Anderson Cancer Center | Houston | United States | 9 |
| Weill Cornell Medical College - New York - Presbyterian Hospital | New York | United States | 1 |
| West Virginia University/Mary Babb Randolph Cancer Center | Morgantown | United States | 1 |